Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Culture medium for 3D culture of ovarian cancer tissue

A culture medium and ovarian cancer technology, applied in the field of 3D culture medium of ovarian cancer tissue, can solve the problems of low inoculation success rate, inability to fully reflect drug metabolism process, drug efficacy and side effects, and long experiment cycle, etc., to achieve Good activity characteristics, the effect of maintaining tissue cell specificity

Active Publication Date: 2019-04-19
ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
View PDF13 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In 2D culture, tumor cells are very different from their in vivo state in terms of morphology, differentiation, expansion, metabolic response to stimuli, and gene protein expression. For the animal evaluation system, the success rate of inoculation is low, and the experimental cycle Long, but also due to the large species differences with humans, it cannot fully reflect the metabolic process, efficacy and side effects of drugs in the human body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Culture medium for 3D culture of ovarian cancer tissue
  • Culture medium for 3D culture of ovarian cancer tissue
  • Culture medium for 3D culture of ovarian cancer tissue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] A medium for 3D culture of ovarian cancer tissue, its formula is as follows: cytokine B27 50-fold dilution; N-acetylcysteine ​​1mM; EGF 50ng / ml; Noggin 100ng / ml; R-spondin 1 250ng / ml; A83-01200n M; FGF 10 50ng / ml; Niacinamide 10mM; Y-27632 (ie: ROCK specific pathway blocker) 10μM; glutamax 100-fold dilution; N2Supplement 100-fold dilution; Hormone 0.5μM; progesterone 5ng / ml.

Embodiment 2

[0038] A medium for 3D culture of ovarian cancer tissue, its formula is as follows: cytokine B27 50-fold dilution; N-acetylcysteine ​​1.2mM; EGF 45ng / ml; Noggin 90ng / ml; R-spondin 1 220ng / ml; A83- 01150n M; FGF 10 60ng / ml; Nicotinamide 20mM; Y-27632 (ie: ROCK specific pathway blocker) 15μM; glutamax 100-fold dilution; N2Supplement 100-fold dilution; b FGF 5ng / ml; Gastrin 0.5nM; ; Estrogen 1 μM; Progesterone 1 ng / ml.

Embodiment 3

[0040] A medium for 3D culture of ovarian cancer tissue, its formula is as follows: cytokine B27 50-fold dilution; N-acetylcysteine ​​0.8mM; EGF 55ng / ml; Noggin 110ng / ml; R-spondin 1 200ng / ml; 01250n M; FGF10 40ng / ml; Niacinamide 5mM; Y-27632 (ie: ROCK specific pathway blocker) 5μM; glutamax 100-fold dilution; N2Supplement 100-fold dilution; bFGF 3ng / ml; Gastrin 1.5nM; Vitamin E 1mM ; Estrogen 0.8μM; Progesterone 10ng / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a culture medium for 3D culture of ovarian cancer tissue, the tissue is prepared from cytokine B27, N-acetylcysteine, R-spondin 1, A83-01, epidermal growth factors, glutamine,N2Supplement, estrogen, progesterone and vitamin E. The culture medium includes various cytokines and signal pathway regulatory factors which are needed by ovarian cancer tissue cell culture, mutually, directly and closely affect each other and coordinate with each other, so that the ovarian cancer tissue cells can better display the inherent active characteristics in the process of culture, and the overall characteristic highly similar to the living ovarian cancer tissue is achieved, and ovarian tumor cells subjected to 3D culture with the culture medium are clustered and are hypoxic in the middle and similar to the ovarian tumor tissue.

Description

technical field [0001] The invention belongs to the field of biomedicine and discloses a medium for 3D culture of ovarian cancer tissue. Background technique [0002] Currently, the in vitro methods for screening and evaluating antineoplastic drugs are mainly 2D culture systems of tumor cells, while the methods for in vivo screening and evaluation mainly use animal models. In 2D culture, tumor cells are very different from their in vivo state in terms of morphology, differentiation, expansion, metabolic response to stimuli, and gene protein expression. For the animal evaluation system, the success rate of inoculation is low, and the experimental cycle Long, but also due to the large species differences with humans, it cannot fully reflect the metabolic process, efficacy and side effects of drugs in the human body. [0003] As a new method for recent oncology research, human tissue organoid culture technology uses mature human cells to cultivate human tissue organoids under ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/09
CPCC12N5/0693C12N2500/32C12N2500/38C12N2501/11C12N2501/20C12N2501/30C12N2513/00
Inventor 王勇郑鸿平黄敏
Owner ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products